Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -10.76 |
peg ratio | 0.12 |
price to book ratio | 2.72 |
price to sales ratio | 3.13 |
enterprise value multiple | -17.41 |
price fair value | 2.72 |
profitability ratios | |
---|---|
gross profit margin | 65.89% |
operating profit margin | -28.3% |
pretax profit margin | -27.93% |
net profit margin | -28.99% |
return on assets | -19.47% |
return on equity | -25.12% |
return on capital employed | -21.83% |
liquidity ratio | |
---|---|
current ratio | 4.90 |
quick ratio | 4.12 |
cash ratio | 3.28 |
efficiency ratio | |
---|---|
days of inventory outstanding | 159.80 |
operating cycle | 208.21 |
days of payables outstanding | 44.53 |
cash conversion cycle | 163.68 |
receivables turnover | 7.54 |
payables turnover | 8.20 |
inventory turnover | 2.28 |
debt and solvency ratios | |
---|---|
debt ratio | 0.09 |
debt equity ratio | 0.12 |
long term debt to capitalization | 0.00 |
total debt to capitalization | 0.11 |
interest coverage | -14,852.50 |
cash flow to debt ratio | 0.46 |
cash flow ratios | |
---|---|
free cash flow per share | 0.21 |
cash per share | 3.30 |
operating cash flow per share | 0.32 |
free cash flow operating cash flow ratio | 0.64 |
cash flow coverage ratios | 0.46 |
short term coverage ratios | 4.16 |
capital expenditure coverage ratio | 2.77 |
Frequently Asked Questions
10x Genomics, Inc. (TXG) published its most recent earnings results on 29-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. 10x Genomics, Inc. (NASDAQ:TXG)'s trailing twelve months ROE is -25.12%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. 10x Genomics, Inc. (TXG) currently has a ROA of -19.47%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
TXG reported a profit margin of -28.99% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.90 in the most recent quarter. The quick ratio stood at 4.12, with a Debt/Eq ratio of 0.12.